Article Details
Retrieved on: 2020-11-23 19:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Merck will acquire clinical-stage <b>biopharmaceutical</b> company OncoImmune for $425 million, per a definitive agreement announced Monday.
Article found on: njbiz.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here